OrbiMed Advisors LLC
This article was originally published in Start Up
Executive Summary
Specialized funds permit an investment team to make use of expertise and contacts developed within a specific industry, but can often leave investors with no place to go when an entire sector goes south. Such is not the case with OrbiMed Advisors, however. While almost entirely focused on the pharmaceutical and biotech industries, OrbiMed's philosophy of investing along a continuum of drug discovery companies globally, from "two guys in a lab with a dream, to Pfizer," and on both the long and short sides of the market, has permitted it to profit during both market upturns and downdrafts.